ATM
Alzamend Neuro enters agreement for $6.5 million ATM offering By Investing.com
Alzamend Neuro, Inc., a biopharmaceutical company focused on developing treatments for neurological and psychiatric disorders, has entered into an At-the-Market…
Read More »ATM fees hit a record high for 4th straight year
(NewsNation) — If you need money from an ATM, and it’s not a machine run by your bank, you’ll be…
Read More »